These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16814640)

  • 61. Quetiapine for acute mania in bipolar disorder.
    Brahm NC; Gutierres SL; Carnahan RM
    Am J Health Syst Pharm; 2007 May; 64(10):1045-53. PubMed ID: 17494904
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neutropenia associated with the comedication of quetiapine and valproate in 2 elderly patients.
    Hung WC; Hsieh MH
    J Clin Psychopharmacol; 2012 Jun; 32(3):416-7. PubMed ID: 22561472
    [No Abstract]   [Full Text] [Related]  

  • 63. Quetiapine in the elderly with parkinsonism and psychosis.
    Wijnen HH; van der Heijden FM; van Schendel FM; Tuinier S; Verhoeven WM
    Eur Psychiatry; 2003 Nov; 18(7):372-3. PubMed ID: 14643568
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Validity of conclusions about quetiapine.
    McIntyre RS
    Am J Health Syst Pharm; 2008 Jan; 65(2):114-5; author reply 115-6. PubMed ID: 18192252
    [No Abstract]   [Full Text] [Related]  

  • 65. Inaccurate information on quetiapine.
    Goldstein JM
    J Clin Psychiatry; 1998 Dec; 59(12):687. PubMed ID: 9921704
    [No Abstract]   [Full Text] [Related]  

  • 66. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E; Santens P
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quetiapine of non-suicidal self-injury associated with dysphoric mania and ultradian cycling bipolar disorder.
    Novis F; Silva AC; Nardi AE; Cheniaux E
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E61-2. PubMed ID: 24026749
    [No Abstract]   [Full Text] [Related]  

  • 68. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.
    Yamauchi K; Ohta K; Taniguchi T; Ohmori T
    Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355
    [No Abstract]   [Full Text] [Related]  

  • 69. The catatonic pupil: An unprivileged entity.
    Agrawal AK; Das S
    Asian J Psychiatr; 2018 Feb; 32():75-76. PubMed ID: 29220780
    [No Abstract]   [Full Text] [Related]  

  • 70. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
    Wijkstra J; Burger H; van den Broek WW; Birkenhäger TK; Janzing JG; Boks MP; Bruijn JA; van der Loos ML; Breteler LM; Ramaekers GM; Verkes RJ; Nolen WA
    Acta Psychiatr Scand; 2010 Mar; 121(3):190-200. PubMed ID: 19694628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clomipramine in the treatment of catatonia].
    Barroso Cañizares A; Jiménez Cano JP; Granada Jiménez O
    Actas Esp Psiquiatr; 1999; 27(4):273-6. PubMed ID: 10469949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
    J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risperidone treatment of febrile catatonia in first-episode psychosis.
    Duggal HS
    Gen Hosp Psychiatry; 2005; 27(1):80-1. PubMed ID: 15694223
    [No Abstract]   [Full Text] [Related]  

  • 76. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.
    Rifkin AE
    J Clin Psychopharmacol; 2008 Jun; 28(3):367; author reply 368. PubMed ID: 18480708
    [No Abstract]   [Full Text] [Related]  

  • 77. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency.
    Potvin S; Stip E; Roy JY
    Can J Psychiatry; 2004 Oct; 49(10):711. PubMed ID: 15560324
    [No Abstract]   [Full Text] [Related]  

  • 78. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.
    Dawdy P
    J Clin Psychopharmacol; 2008 Jun; 28(3):367-8; author reply 368. PubMed ID: 18480707
    [No Abstract]   [Full Text] [Related]  

  • 79. A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy.
    Bai Y; Yang X; Zeng Z; Yang H
    BMC Psychiatry; 2018 Mar; 18(1):67. PubMed ID: 29534691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
    Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
    Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.